Harmonix

SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.

ATLAS Space Operations, Inc. specializes in revolutionizing satellite communications through its innovative software platform. Founded in 2015 and headquartered in Traverse City, Michigan, the company offers the ATLAS Freedom Software Platform, a cloud-based space management and control system. This platform enables users to gather and process data from space efficiently, featuring capabilities such as flexible scheduling, cloud processing, and integration with AWS services. ATLAS also operates a global network of antennas to provide affordable and scalable ground communication solutions. With a focus on improving the accessibility and affordability of space-based communications, ATLAS aims to transform the industry and enhance how data from satellites is utilized on Earth.

Attivare Therapeutics focuses on the development of biomaterial-based vaccines aimed at enhancing immune responses against tumors that exhibit low immunogenicity. The company’s innovative approach involves creating a specialized microenvironment within the body that concentrates immune cells and delivers immunomodulatory agents to these cells. This strategy is designed to effectively reprogram the immune response, breaking tolerance to cancer antigens. By leveraging this technology, Attivare Therapeutics enables researchers to develop bioactive components that significantly improve the magnitude and durability of immune responses in patients.

Sorcero, Inc. is a technology company based in Washington, D.C., founded in 2017, that specializes in developing a no-code, AI-powered platform designed for decision support and knowledge management. The Sorcero Language Intelligence Platform caters primarily to experts in medical, insurance, and engineering fields, enabling them to manage and analyze complex, high-volume data effectively. This platform is utilized for various applications, including enhancing medical claims investigations, supporting life insurance underwriting, and monitoring real-time medical guidelines. Sorcero's innovative approach has earned it recognition as a leader in the digital health and insurtech sectors, receiving accolades from industry organizations for its contributions to improving patient outcomes and decision-making processes in life sciences.

xCures, Inc. is a company focused on transforming cancer treatment through its innovative AI-based precision oncology platform, established in 2018 and headquartered in Los Altos, California. The platform addresses the limitations of traditional drug-centric approaches by integrating cancer research with patient care. It operates as a perpetual trial, continuously collecting Real World Evidence (RWE) to enhance decision-making in treatment recommendations for advanced cancer patients. By utilizing machine learning, xCures structures insights from tumor boards and matches patients with the most effective treatment options based on their individual cases. This approach not only streamlines the process for healthcare providers but also reduces the time and cost associated with drug development, ultimately aiming to improve patient outcomes and save lives.

Strateos specializes in automating chemistry, biology, and tissue analysis in closed-loop robotic labs, accelerating drug discovery programs for pharmaceutical partners. By combining advanced robotics, software for imaging and analytics, and remote cloud laboratories, Strateos enables more rapid and efficient discovery of new drug candidates. The company was formed through a merger of Transcriptic, which developed the first robotic cloud laboratory platform for life science research, and 3Scan, which specialized in automating tissue analysis. Strateos aims to express life science methods as data, enabling infrastructure virtualization and driving the next generation of discovery with significant time and cost efficiencies.

Sana Health, Inc. is a digital health company specializing in a bio-therapeutic device aimed at fostering relaxation to alleviate pain and tension. The company has developed a non-addictive mask and headphone system that employs audio-visual stimulation to enhance the balance between the brain's left and right hemispheres, facilitating a deep state of meditation. This innovative device uses coordinated pulses of light and sound to guide users into a restorative state, thereby improving mental well-being and addressing chronic pain and insomnia. In addition to the hardware, Sana Health offers a mobile application available on both the App Store and Google Play, allowing users to access its features conveniently. Founded in 2015 and headquartered in Lafayette, Colorado, with an additional office in Mill Valley, California, Sana Health is involved in pivotal studies concerning its technology's applications for conditions such as fibromyalgia and neuropathic pain, as well as trials focusing on anxiety and PTSD.

Scribe Biosciences specializes in single-cell analysis tools that enhance clinical and research applications. The company employs its proprietary technology, Printed Droplet Microfluidics (PDM), which allows for flexible and reconfigurable fluid handling at the picoliter scale. By utilizing fluorescence-activated microfluidic droplet sorting along with a specialized substrate, Scribe Biosciences can manipulate single cells and fluid aliquots with high throughput. This innovative approach aids researchers and healthcare professionals in gaining insights into various processes, particularly those related to infectious diseases and cancer.

Scribe Biosciences specializes in single-cell analysis tools that enhance clinical and research applications. The company employs its proprietary technology, Printed Droplet Microfluidics (PDM), which allows for flexible and reconfigurable fluid handling at the picoliter scale. By utilizing fluorescence-activated microfluidic droplet sorting along with a specialized substrate, Scribe Biosciences can manipulate single cells and fluid aliquots with high throughput. This innovative approach aids researchers and healthcare professionals in gaining insights into various processes, particularly those related to infectious diseases and cancer.

SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.

ATLAS Space Operations, Inc. specializes in revolutionizing satellite communications through its innovative software platform. Founded in 2015 and headquartered in Traverse City, Michigan, the company offers the ATLAS Freedom Software Platform, a cloud-based space management and control system. This platform enables users to gather and process data from space efficiently, featuring capabilities such as flexible scheduling, cloud processing, and integration with AWS services. ATLAS also operates a global network of antennas to provide affordable and scalable ground communication solutions. With a focus on improving the accessibility and affordability of space-based communications, ATLAS aims to transform the industry and enhance how data from satellites is utilized on Earth.

Visicell Medical is a company focused on developing innovative medical imaging technology that enhances the early detection and diagnosis of diseases. It specializes in creating safe and biodegradable stem cell tracking tools, which facilitate real-time monitoring of stem cells implanted in patients. These tools are designed for use in both clinical and pre-clinical settings, allowing healthcare professionals to track stem cell progress effectively. In addition to stem cell tracking, Visicell Medical offers specialized image capture systems and analysis tools that provide high-resolution, three-dimensional views of tissues and cells. This technology aids in the identification of abnormalities, enabling earlier intervention and improved treatment outcomes for patients, while also aiming to reduce overall healthcare costs.

Aether Bio is a technology company that focuses on re-purposing enzymes to create new compounds using machine learning. By integrating machine learning with high-throughput robotic laboratories, Aether Bio engineers enzymes rapidly and enables massively parallelized experimentation. This innovative approach generates significantly larger datasets compared to competitors, allowing researchers to manufacture complex and novel products more efficiently and at a lower cost. The company's technology aims to provide healthcare institutions with sustainable and affordable chemicals and materials essential for their operations.

Trials.ai operates an innovative online platform that streamlines the management of clinical trials for life science organizations. Founded in 2016 and based in San Diego, California, the platform integrates various functionalities, including electronic data capture (EDC), clinical trial management systems (CTMS), electronic patient-reported outcomes (ePRO), and analytics, into a single system. This comprehensive approach aids researchers in efficiently navigating trial protocols, managing patient eligibility, scheduling visits, and tracking essential events. Leveraging artificial intelligence, Trials.ai's Smart Protocol system enhances trial design by analyzing extensive data from its codified clinical trials database, providing insights that help trial sponsors optimize their protocols for greater speed and success. By addressing the challenges posed by siloed data and inefficient designs, Trials.ai aims to accelerate the delivery of effective treatments to patients, ultimately reducing the high costs and failures associated with clinical trials.

Qu Biologics Inc. is a biotechnology company based in Burnaby, Canada, founded in 2007, that specializes in developing immunotherapies aimed at restoring normal immune function. The company's primary focus is on Site Specific Immunomodulators (SSIs), which are designed to activate the body’s immune system to combat chronic inflammation associated with conditions such as cancer and inflammatory bowel disease (IBD). Qu Biologics has treated over 270 patients with advanced cancer and severe immune-related diseases through a compassionate use program, yielding promising preliminary outcomes that support further investigation in controlled clinical trials. Currently, the company is recruiting participants for a Phase 1/2 clinical trial specifically targeting Crohn’s disease. Qu Biologics aims to enhance the survival and quality of life for individuals affected by cancer and debilitating immune-related disorders like Crohn’s disease, ulcerative colitis, and rheumatoid arthritis.

Pathology Watch Inc. is a company based in Salt Lake City, Utah, that specializes in providing remote specimen interpretation services to hospitals, laboratories, and dermatology centers through its digital pathology solution. Founded in 2017, the company collaborates with dermatopathologists and sub-specialized pathologists to interpret digital slides, pathology reports, and biopsy slides. Additionally, Pathology Watch offers telepathology services, facilitating large clinics and hospitals in enhancing their pathology workflows. By digitizing these processes, the company aims to improve patient care quality, reduce costs, and create new revenue opportunities for healthcare providers.

Halo Industries, Inc. is a technology company based in San Mateo, California, that specializes in developing advanced laser-based hardware solutions for material processing. Founded in 2014, the company focuses on enhancing operational efficiency and product quality in various industries, including solar, semiconductor, LED, battery, and power electronics. Its automated production line tools are designed to reduce costs and improve energy output in solar thermal systems, positioning Halo Industries as a key player in the advancement of next-generation technologies within these sectors.

xCures, Inc. is a company focused on transforming cancer treatment through its innovative AI-based precision oncology platform, established in 2018 and headquartered in Los Altos, California. The platform addresses the limitations of traditional drug-centric approaches by integrating cancer research with patient care. It operates as a perpetual trial, continuously collecting Real World Evidence (RWE) to enhance decision-making in treatment recommendations for advanced cancer patients. By utilizing machine learning, xCures structures insights from tumor boards and matches patients with the most effective treatment options based on their individual cases. This approach not only streamlines the process for healthcare providers but also reduces the time and cost associated with drug development, ultimately aiming to improve patient outcomes and save lives.

Auransa Inc., founded in 2014 and based in Palo Alto, California, is a clinical stage drug development company focused on creating innovative treatments for challenging diseases, including cancer, autoimmune, and neurological disorders. Utilizing a proprietary artificial intelligence platform, Auransa analyzes extensive genomic data from human disease tissues to study molecular subtypes of diseases. This approach allows the company to predict potential drug compounds and identify targets tailored for specific patient populations. Currently, Auransa's internal drug pipeline features a first-in-class investigational new drug for cancer that is undergoing clinical trials. The company actively collaborates with various partners in the biopharma sector to advance its drug development efforts.

Rad AI, Inc. is a company based in Berkeley, California, that specializes in developing an artificial intelligence platform designed to automate report generation for radiologists. Founded in 2018, Rad AI's solution streamlines the radiology workflow by automating repetitive tasks, thereby enhancing efficiency and accuracy while addressing issues of clinician burnout. The platform utilizes AI to generate report impressions, allowing radiologists to dictate findings using voice recognition technology, identify errors, and customize recommendations. By integrating smoothly with existing workflows, Rad AI aims to improve patient care and support radiologists in delivering accurate and timely reports.

Sana Health, Inc. is a digital health company specializing in a bio-therapeutic device aimed at fostering relaxation to alleviate pain and tension. The company has developed a non-addictive mask and headphone system that employs audio-visual stimulation to enhance the balance between the brain's left and right hemispheres, facilitating a deep state of meditation. This innovative device uses coordinated pulses of light and sound to guide users into a restorative state, thereby improving mental well-being and addressing chronic pain and insomnia. In addition to the hardware, Sana Health offers a mobile application available on both the App Store and Google Play, allowing users to access its features conveniently. Founded in 2015 and headquartered in Lafayette, Colorado, with an additional office in Mill Valley, California, Sana Health is involved in pivotal studies concerning its technology's applications for conditions such as fibromyalgia and neuropathic pain, as well as trials focusing on anxiety and PTSD.

Volumetric, Inc. is a Houston-based company that specializes in advanced biomaterials and biofabrication through its innovative 3D bioprinting platform. Founded in 2014, Volumetric focuses on creating vascularized human tissue and developing bioprinters and bio inks for a range of applications, including life sciences, drug discovery, and medical devices. The company's technology aims to enhance research in biomaterials, cancer treatments, and the potential replacement of human organs, positioning it at the forefront of developments in regenerative medicine and tissue engineering.

Ancilia Biosciences focuses on developing engineered bacterial therapies aimed at treating diseases associated with the microbiome. The company specializes in creating virus-resistant live bacterial products that modulate the human microbiome, specifically targeting the viral components within the gut microbiome. By concentrating on healthy gut bacteria and their predatory phages, Ancilia engineers resistant bacterial strains to combat diseases. Its innovative approach includes the development of a new class of live biotherapeutics that allows medical professionals to target specific phages or viruses that induce lysis, with applications in immunology and oncology.

GEn1E Lifesciences Inc. is a biotechnology company based in Palo Alto, California, focused on developing innovative therapies for inflammatory and age-related diseases. Established in 2018, GEn1E employs a unique artificial intelligence platform to expedite the drug development process, targeting multiple mechanisms of action for protein therapeutics. Their portfolio includes MUC1-ED, an antibacterial therapy for pseudomonas infections, and a robust pipeline of over 21 novel immunomodulatory therapies aimed at rare diseases that currently lack effective treatments. The company’s AI-driven approach aims to significantly reduce the time and costs associated with drug development, with plans to advance additional therapies to investigational new drug (IND) status within the next year. GEn1E's team, comprised of experienced professionals in drug development and machine learning, is dedicated to creating life-saving treatments for patients in need, addressing the substantial unmet medical demands in the field.

Juvena Therapeutics, Inc. is a biopharmaceutical company based in San Mateo, California, founded in 2017. The company specializes in developing protein-based therapeutics aimed at promoting tissue rejuvenation and addressing age-related diseases in the elderly. Its innovative platform focuses on discovering novel therapeutics that restore cellular functions, targeting conditions such as sarcopenia, wound healing, and neural regeneration. By decoding secreted proteins, Juvena Therapeutics aims to provide solutions for chronic and rare diseases, enhancing the quality of life for aging populations.

Bioz Inc. is a technology company that has developed a cloud-based platform utilizing natural language processing (NLP) and artificial intelligence (AI) to aid scientific researchers in the life sciences. Founded in 2013 and based in Palo Alto, California, Bioz offers a search engine that allows life scientists in academia and biopharma to efficiently find, compare, and select the appropriate reagents, instruments, and consumables for their experiments. The platform includes features such as full-text analysis, relevancy ranking, and a product rating system, all designed to enhance the research process. By analyzing data from the materials and methods sections of peer-reviewed articles, Bioz helps researchers identify key insights and correlations, ultimately accelerating scientific discovery and increasing the likelihood of successful outcomes in drug development and disease treatment.

Pragma Bio is a biotechnology company focused on developing microbiome-based therapies for cancer and autoimmune diseases. Founded in 2018 in Millbrae, California, by Peter McCaffrey, Kovi Bessoff, Ayin Vala, and Kareem Barghouti, the company utilizes proprietary genomic sequencing, artificial intelligence, and synthetic biology techniques to identify biomarkers and therapeutics for complex immunologic disorders. Its innovative platform aggregates extensive public and private data to create a microbiome database, enabling the discovery of connections between biologically relevant data. By using this analytical approach, Pragma Bio aims to identify novel biomarkers that can help stratify patient risk and predict clinical outcomes. The company emphasizes the importance of understanding the gut-immune axis and employs machine learning to enhance the drug discovery process, offering a more efficient alternative to traditional methods and aiming to deliver improved medicines to patients more rapidly and cost-effectively.

Viscient Biosciences is a biotechnology company based in San Diego, California, founded in 2017. The company specializes in drug discovery and development, leveraging innovative human 3D tissue technology combined with multi-omics analysis, which includes genomics, transcriptomics, and metabolomics. This approach allows Viscient to identify genes and pathways that contribute to disease progression, with an initial focus on non-alcoholic steatohepatitis, commonly known as fatty liver disease. The team at Viscient comprises experienced scientists and entrepreneurs from Organovo and Ardea Biosciences, and they aim to transform the traditional drug discovery process, moving away from reliance on animal models to more effective human-based methodologies.

Nelumbo Inc. is a materials innovation company based in Menlo Park, California, focused on developing advanced structural materials for the heating and cooling industry. Founded in 2015, the company specializes in manufacturing thin superomniphobic coatings, such as Ice-Nein and Omniphobe. These coatings enhance the performance of cooling coils in refrigeration and air conditioning systems by reducing frost buildup and improving energy efficiency, thereby minimizing equipment downtime and corrosion. Nelumbo's technology aims to unlock significant market opportunities by contributing to reductions in carbon emissions and energy consumption globally.

ATLAS Space Operations, Inc. specializes in revolutionizing satellite communications through its innovative software platform. Founded in 2015 and headquartered in Traverse City, Michigan, the company offers the ATLAS Freedom Software Platform, a cloud-based space management and control system. This platform enables users to gather and process data from space efficiently, featuring capabilities such as flexible scheduling, cloud processing, and integration with AWS services. ATLAS also operates a global network of antennas to provide affordable and scalable ground communication solutions. With a focus on improving the accessibility and affordability of space-based communications, ATLAS aims to transform the industry and enhance how data from satellites is utilized on Earth.

Prime Movers Lab, established in 2018 and headquartered in Jackson, Wyoming, is a venture capital firm focusing on early-stage investments in deep technology companies. It primarily invests in sectors such as energy, transportation, infrastructure, manufacturing, and agriculture, seeking to support startups that are reinventing these industries. The firm typically invests between $0.25 million and $5 million in equity, without taking board seats or acquiring controlling stakes. It does not lead investments, make co-investments, or invest in publicly listed securities. Prime Movers Lab provides comprehensive resources and integrated coaching to its portfolio companies, leveraging in-depth academic research, commercialized intellectual property, and mentorship from renowned scientists to enhance their chances of success.

SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.

Halo Industries, Inc. is a technology company based in San Mateo, California, that specializes in developing advanced laser-based hardware solutions for material processing. Founded in 2014, the company focuses on enhancing operational efficiency and product quality in various industries, including solar, semiconductor, LED, battery, and power electronics. Its automated production line tools are designed to reduce costs and improve energy output in solar thermal systems, positioning Halo Industries as a key player in the advancement of next-generation technologies within these sectors.

Abalone Bio, Inc. is a biotechnology company based in Richmond, California, established in 2017. The company specializes in developing full-spectrum antibody drugs aimed at treating various conditions, including pain, inflammatory diseases, rare cancers, and rare kidney diseases. One of its primary focuses is on creating a drug for peripheral neuropathy. Abalone Bio employs innovative techniques that utilize libraries of yeast cells expressing antibody variants to either activate or inhibit specific drug targets, facilitating the production of recombinant protein versions of its antibodies. This approach allows for the confirmation of their efficacy through human cell assays, ultimately enabling medical practitioners to address rare diseases more effectively.

Tarana Wireless, Inc. is focused on the research, development, and commercialization of non-line-of-sight (NLoS) wireless transport solutions. Its flagship product, AbsoluteAir 2 (AA2), offers advanced capabilities such as deterministic True NLOS performance, extensive coverage, and high spectral efficiency. The company provides a comprehensive solution, including installation services by construction-grade crews and a carrier-class element management system for configuring and monitoring AA2 nodes. Tarana's technology supports a variety of applications, including small-cell backhaul, wireless fiber extension, and residential broadband access, catering primarily to tier-1 operators globally. Founded in 2009, the company is headquartered in Milpitas, California, with additional offices in Berkeley and Pune, India.

DermaSensor, Inc. is a Miami-based company that develops a handheld device designed to evaluate skin lesions for cancer using artificial intelligence and spectroscopy. Founded in 2009, the company's flagship product enables both physicians and consumers to conduct skin checks conveniently in clinical settings and at home. The device employs elastic scattering spectroscopy and machine learning algorithms to rapidly assess skin lesions, helping to identify potential cancerous cells. By providing an affordable and efficient tool for early detection, DermaSensor aims to improve access to skin cancer evaluations, addressing the significant number of Americans who have never undergone such checks. The technology not only facilitates immediate assessments but also alerts users when cancerous cells are detected, streamlining the process of skin cancer diagnostics.

Mathison is a technology company that specializes in diversity hiring and retention. Its platform provides a comprehensive solution for organizations looking to enhance their diversity, equity, and inclusion (DEI) efforts. This includes tools for top-of-funnel diversity sourcing, bias reduction in hiring processes, and strategies to engage the entire team in diversity initiatives. Mathison's services cater to a variety of clients, including well-known brands, and focus on sourcing underrepresented candidates while ensuring job seekers' identities are protected. The platform also functions as a recruitment marketplace, centralizing talent networks to facilitate personalized job opportunities and effective DEI strategy management.

Terramera, founded in 2009 and based in Vancouver, Canada, specializes in developing and manufacturing plant-based pesticides and fertilizers as alternatives to conventional chemical products. The company offers solutions such as Proof for bed bug and dust mite control, Actigate as an organic pesticide, and Rango for pest control and crop protection. Terramera's technology platforms integrate artificial intelligence, science, and nature to promote sustainable farming practices, aiming to create a healthy and safe environment free from toxic chemicals. This approach supports farmers in achieving improved yields and profits through organic and sustainable methods.

REITIUM is a real estate marketplace designed to democratize property investment, allowing individuals to become real estate investors with an initial investment of just $100. By leveraging blockchain-based technology, REITIUM simplifies the process of buying real estate and removes traditional barriers to entry, making it accessible to a broader audience, including millennials, seniors, and individuals from developing countries. The platform enables users to participate in fractional ownership, allowing them to share in rental income and property appreciation. Through a straightforward five-step process, users can create an account, fund their wallet, browse and purchase properties, collect dividends, and monitor their investments, all while having the option to sell at any time. This innovative approach aims to unlock the potential of the vast amounts of capital that have previously been unable to enter the real estate market.

Unlimited Tomorrow, Inc. specializes in developing advanced prosthetic technologies, including 3D scanning, 3D printing, and machine learning-based artificial limbs for amputees. Founded in 2014 and located in Rhinebeck, New York, the company creates robotic arms and legs that can be controlled by the user's thoughts, enhancing the user experience. By employing 3D scanning to customize the design of each prosthetic limb according to the individual's unique anatomy, Unlimited Tomorrow aims to provide affordable solutions for differently-abled individuals, particularly in remote and underserved communities. The company's commitment to open-source technology further facilitates access to its innovative products, ensuring that they can reach those in need.

Upward Farms operates an indoor aquaponic farm that specializes in cultivating leafy greens and fish while adhering to high ecological and quality standards. By integrating modern vertical farming techniques with the ancient practice of aquaponics, the company creates a sustainable ecosystem where fish fertilize crops. This innovative approach allows for the growth of USDA-certified organic microgreens and hybrid striped bass, which are produced without the use of antibiotics, hormones, or mercury. Upward Farms aims to provide customers with convenient, local, and ready-to-eat food products that nourish individuals and contribute positively to the environment.

Upward Farms operates an indoor aquaponic farm that specializes in cultivating leafy greens and fish while adhering to high ecological and quality standards. By integrating modern vertical farming techniques with the ancient practice of aquaponics, the company creates a sustainable ecosystem where fish fertilize crops. This innovative approach allows for the growth of USDA-certified organic microgreens and hybrid striped bass, which are produced without the use of antibiotics, hormones, or mercury. Upward Farms aims to provide customers with convenient, local, and ready-to-eat food products that nourish individuals and contribute positively to the environment.

Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

Momentus Inc. is a commercial space company based in Santa Clara, California, founded in 2017. The company specializes in providing water-powered transportation services for spacecraft and aims to offer a range of in-space infrastructure services. These services include in-space transportation, hosted payloads, and in-orbit servicing, facilitated by its planned transfer and service vehicles. Momentus is developing an innovative water plasma-based propulsion system to enable efficient movement of satellites and payloads between orbits. By focusing on space transportation, satellite services, and in-orbit servicing, Momentus positions itself as a key player in the evolving space economy.

Babylon Micro-Farms Inc., founded in 2017 and based in Charlottesville, Virginia, specializes in providing indoor farming solutions that empower individuals and communities to grow their own produce. The company offers a smart, scalable indoor farming platform designed for a variety of crops, including leafy greens, herbs, microgreens, and edible flowers. By leveraging remote management technology, Babylon Micro-Farms aims to create a decentralized network of micro-farms across North America, making sustainable hydroponic farming more accessible. Their innovative systems automate the growing process, significantly reducing water usage, food waste, and pollutants while allowing year-round cultivation. Additionally, Babylon Micro-Farms has developed low-cost micro-farms to support food-insecure populations, particularly refugees in the Middle East, highlighting their commitment to addressing food security through sustainable agriculture.

Prime Movers Lab, established in 2018 and headquartered in Jackson, Wyoming, is a venture capital firm focusing on early-stage investments in deep technology companies. It primarily invests in sectors such as energy, transportation, infrastructure, manufacturing, and agriculture, seeking to support startups that are reinventing these industries. The firm typically invests between $0.25 million and $5 million in equity, without taking board seats or acquiring controlling stakes. It does not lead investments, make co-investments, or invest in publicly listed securities. Prime Movers Lab provides comprehensive resources and integrated coaching to its portfolio companies, leveraging in-depth academic research, commercialized intellectual property, and mentorship from renowned scientists to enhance their chances of success.

PolySpectra, Inc. is a company based in Berkeley, California, that specializes in developing advanced functional materials for additive manufacturing. Founded in 2016, PolySpectra focuses on transforming 3D printing from a prototyping tool into a viable production method. The company utilizes light-activated catalysts to create durable, stereolithographic resins suitable for consumer applications. Its modular platform allows for the delivery of materials with a wide range of tailored properties derived from a single chemical system. By providing these innovative materials, PolySpectra aims to assist inventors, designers, and engineers in bringing their concepts to life.

Partsium is a B2B market place that facilitates the commercialization of automotive parts.

Amaz Project offers energy drinks that include yerba mate, green tea, guarana, acerola berries, suma root, and yanomami mushrooms. They sell their products online. The company's contact modes are mail and physical address.

PreciPoint GmbH is a leading provider of digital microscopy solutions, specializing in the design, development, and manufacturing of advanced digital microscopes and associated software. Founded in 1982 and based in Freising, Germany, the company operates a manufacturing facility in Thüringen. PreciPoint offers a comprehensive range of products, including smart microscopes, x-y-stages, electronic control systems, and automated testing systems. It also provides software solutions such as ViewPoint for virtual slide viewing and ScanPoint for whole slide scanning. By integrating laboratory information management software and AI-powered image analysis, PreciPoint enhances the capabilities of pathology labs, enabling them to deliver efficient and innovative diagnostic services. The company’s unique approach focuses on understanding laboratory workflows, facilitating improved outcomes in cancer diagnostics and pathology.

LifeGuides, PBC specializes in providing stress consulting services to employers, aimed at supporting employees through various life challenges. Founded in 2016 and headquartered in Ocala, Florida, the company has created a unique marketplace for life experiences, connecting employees with a community of trained and certified Guides. These Guides offer personalized assistance across more than 400 topics related to personal growth, lifelong learning, and everyday life events. By making experienced and empathetic support readily available, LifeGuides enhances employee wellbeing, leading to increased happiness and productivity. The diversity within the Guides Community enriches the support offered, allowing employees to select a Guide who has successfully navigated similar challenges, making the experience more relatable and approachable than traditional therapy.